Topics

Sep. 30, 2011

Tildipirosin synthesized in IMC is launched in Europe as an animal drug ZUPREVO. more »

Aug. 1, 2011

Laboratory of Virology was reorganized as Laboratory of Basic Biology. Resources Management Section was established.

Jun. 13, 2011

Dr. Masakatsu Shibasaki, IMC Representative Director, is going to attend The Nobel Prize Symposium as a panelist.
more »

Apr. 1, 2011

MCRF was reincorporated on April 1, 2011, as a public-interest foundation.

Feb. 3, 2011

【Topic from Farumasia, the monthly magazine of The Pharmaceutical Society of Japan.】
Dr. Masakatsu Shibasaki, Director of IMC, received The Special Award, the Society of Synthetic Organic Chemistry, Japan in September 2010. Dr. Hirai, Director of The Pharmaceutical Society of Japan, offered his congratulations on this occasion in Farumashia Vol. 1, 2011.
more »

Jan. 31, 2011

CPZEN-45, which is being developed as anti TB (including MDR-TB and XDR-TB) drug in IMC, was introduced in Nature, 27 Jan 2011 Vol.469.
Please refer to "Projects" on this web site for CPZEN-45. more »

Dec. 22, 2010

【Clinical Development of Immunosuppressant Spanidin】
Spanidin is a chemically synthesized immunosuppressant, which was developed in collaboration with IMC, Takara Shuzo and Nippon Kayaku.
Nordic Pharma Group will conduct further clinical development of Spanidin, which includes a comparative Phase III study for patients suffering from Wegener's Granulomatosis relapse. more »